Trade names Emilace (JP) ATC code none CAS Number 75272-39-8 | Routes of
administration Oral Legal status Rx-only (JP) Molar mass 387.9 g/mol | |
 | ||
AHFS/Drugs.com International Drug Names | ||
How to pronounce nemonapride
Nemonapride (エミレース, Emilace ()) is an atypical antipsychotic approved in Japan for the treatment of schizophrenia. It was launched by Yamanouchi in 1991. Nemonapride acts as a D2 and D3 receptor antagonist, and is also a potent 5-HT1A receptor agonist. It has affinity for sigma receptors.
References
Nemonapride Wikipedia(Text) CC BY-SA